Quoin pharmaceuticals announces 2022 corporate update conference call to be held on thursday march 9th at 8:30am et

Ashburn, va., march 02, 2023 (globe newswire) -- quoin pharmaceuticals ltd. (nasdaq: qnrx) (the “company” or “quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announced today that the company intends to release its 2022 fourth quarter and year-end financial results after the market closes on wednesday, march 8, 2023.
QNRX Ratings Summary
QNRX Quant Ranking